MARATTO

article · European Journal of Pharmacology

“Sigma-1 receptor modulation by clemastine highlights its repurposing as neuroprotective agent against seizures and cognitive deficits in PTZ-kindled rats”

202424 citationsZagazig University

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

  • Pharmacological Receptor Mechanisms and Effects
  • Cholinesterase and Neurodegenerative Diseases
  • Neuroscience and Neuropharmacology Research

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1016/j.ejphar.2024.176851

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.